Rapid Micro Biosystems RPID Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -144.2%+15.4pp | -141.1%+36.9pp | -148.8%+49.5pp | -152.1%+67.6pp | -159.6%+82.7pp | |
| Net margin | -145.8%+5.4pp | -140.3%+26.9pp | -145.1%+39.8pp | -145.6%+58.6pp | -151.2%+73.5pp | |
| EBITDA margin | -135.2%+12.9pp | -131.4%+34.6pp | -137.9%+47.8pp | -140.9%+65.8pp | -148.1%+80.6pp | |
| Free cash flow margin | -110.5%+20.4pp | -95%+67.3pp | -126.4%+47.2pp | -126.4%+62.9pp | -130.9%+66.6pp | |
| Returns | ||||||
| Return on equity | -116.7%-64.4pp | -86.8%-38.3pp | -68.8%-23.2pp | -59.2%-16.1pp | -52.3%-12.1pp | |
| Return on assets | -67.8%-25.8pp | -54.5%-15.7pp | -46.6%-8.8pp | -45.8%-9.5pp | -42.1%-7.6pp | |
| Return on invested capital | -120.6%-54.2pp | -93.7%-33.3pp | -77.1%-19.3pp | -87.3%-27.7pp | -66.4%-16.8pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×+0.2× | 0.4×+0.2× | 0.3×+0.1× | 0.3×+0.1× | 0.3×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.6×-2.0× | 3.3×-1.3× | 4.2×-1.3× | 3.7×-2.2× | 4.6×-2.3× | |
| Quick ratio | 1.7×-1.6× | 2.4×-1.1× | 3×-1.2× | 2.4×-2.2× | 3.2×-2.4× | |
| Cash ratio | 0.7×-0.5× | 1.1×+0.1× | 1.2×-0.2× | 1.1×-1.1× | 1.3×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 1.2×+1.1× | 0.7×+0.6× | 0.5×+0.5× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.4×+0.3× | 0.3×+0.3× | 0.3×+0.2× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -24.1×+30.1× | -33.2×-6.1× | -59.1×-41.1× | -119.4×— | -54.2×— | |
| Per Share | ||||||
| Book value per share | $0.45-69.8% | $0.74-57.0% | $0.99-49.0% | $1.22-43.7% | $1.49-39.2% | |
| Valuation | ||||||
| Market capitalization | $86.19M-43.8% | $128.54M+232% | $147.66M+287% | $148.15M+424% | $114.14M+177% | |
| Enterprise value | $95.86M-31.7% | $132.15M+378% | $152.59M+582% | $135.16M+6,020% | $100.8M+293% | |
| Price / sales | 2.5×-2.6× | 3.8×+2.4× | 4.8×+3.4× | 4.9×+3.7× | 3.9×+2.1× | |
| Price / book | 4.2×+1.4× | 3.9×+3.4× | 3.3×+2.9× | 2.7×+2.4× | 1.7×+1.4× | |
| EV / sales | 2.8×-1.8× | 3.9×+2.9× | 5×+4.1× | 4.5×+4.6× | 3.4×+2.3× | |
| Free cash flow yield | -44.3%-19.2pp | -24.8%+92.7pp | -26.1%+92.8pp | -25.8%+139pp | -34%+76.6pp | |
| Earnings yield | -58.5%-29.6pp | -36.7%+84.4pp | -30%+96.7pp | -29.8%+149pp | -39.3%+86.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Rapid Micro Biosystems's ratios come from?
- Every ratio is computed from Rapid Micro Biosystems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
